✉news HealthMedicine first seen 4 d ago, last 3 d ago, peak #29
Oncolytic virus trial offers hope for metastatic pancreatic cancer
Original: Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial
A randomized phase 2b trial published in Nature tested an intravenous oncolytic adenovirus engineered to express hyaluronidase, combined with chemotherapy, in patients with metastatic pancreatic cancer. The approach aims to break down the tumor's dense stroma so the virus and drugs can penetrate more effectively. The findings are drawing attention because pancreatic cancer remains one of the hardest malignancies to treat, with very limited options once it spreads.
Why now: Pancreatic cancer has an extremely poor prognosis, so any novel therapeutic trial result attracts wide medical and public interest.
Naturemetastatic pancreatic canceroncolytic adenovirushyaluronidasechemotherapy
Rank over time, top of the chart is #1. 4 snapshots from 4 d ago to 3 d ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/572796